AMSBIO has launched, at the ‘Frontiers in Stem Cells & Cancer' EMBL-EMBO Symposium**, a guide that illustrates a variety of organoids grown from different tissues by leading international research groups using BME 2 reduced growth factor extracellular matrix that is available from the company.
from The Medical News http://ift.tt/1C4q7oH
from The Medical News http://ift.tt/1C4q7oH
No comments:
Post a Comment